Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study
暂无分享,去创建一个
J. Briones | O. Casasnovas | S. Robson | M. Dreyling | C. Wendtner | S. Rule | A. Carella | F. Zaja | C. Pocock | S. Nick | W. Barreto | L. MacGregor | R. Tschopp